Join EVERSANA and global healthcare leaders as they convene at ISPOR 2026, the leading global conference for Health Economics and Outcomes Research (HEOR).
Our global Value & Evidence. Data & Analytics, Global Pricing, and Market Access experts will be onsite to discuss how we use a variety of analytics, evidence generation, and evidence synthesis activities to help support market access and reimbursement for pharmaceutical and medical devices.
Schedule a meeting with one of our experts to discuss your business needs and visit us in Booth #417.
Read the Latest from our Experts:
- Preparing for Joint Clinical Assessments: How Early PICO Planning Ensures Smoother Submissions
- Strategic PICO Planning: Enhancing Early-Phase Development for Market Access
- Utilization of Indirect Treatment Comparison (ITC), External Control Arms (ECA) and Patient-Reported Outcome Measures (PROMs)
- Predictive Analytics Compendium: Harnessing the Transformative Power of Machine Learning in Healthcare
- National Institutes of Health Taps EVERSANA for Research on the Impact of Rare Disease on Patients, Healthcare System
Featured in ISPOR Value & Outcomes Spotlight – an HEOR News magazine
The latest work from our experts Pamela Vo and Shivani Shah – Predicting PICOs Under EU Joint Clinical Assessment: Is One Method Enough? is featured in the March/April issue of Value & Outcomes Spotlight – ISPOR’s official HEOR News magazine. Read their article.
EVERSANA’s 2026 Poster Presentations
We are proud to present an oral presentation and several posters at this year’s ISPOR conference.
Monday, May 18 – Poster Session 1
- HPR10: The cost-effectiveness and global reimbursement landscape for denosumab in oncology
Authors: Kunal Shastri, MSc, Nathashi Jayawardena, MSc, Kerise Clarke, MSc, Margaret H. Ainslie-Garcia, MSc
- MSR34: Assessment of Autonomous Literature Review Systems for Umbrella Review Screening
Authors: Kevin Kallmes, BS, MA, JD, Vicki Young, MD, Elizabeth Salvo-Halloran, MS, Sumeet Singh, BSc, MSc, Nicole Ferko, MSc
- SA2: Evidence base for Joint Clinical Assessment: a Clinical Systematic Literature Review of OAV101 IT and Comparators for Spinal Muscular Atrophy
Authors: Nicholas Riley, BEc, GradDip Clin Epi & Biostat, Grace McCarthy, MSc, Sarah Kane, Jose Esguerra, Sara A. Kulinski, Pamela Vo, MS, PharmD, Christopher Drudge
- EE5: Budget Impact of Continuous Ambulatory ECG Monitoring: A Real-World Data Model
Author: Pierantonio Russo
- PCR15: Patient preferences for treatment selection in non-muscle invasive bladder cancer (NMIBC): a systematic literature review
Authors: Takahiro Osawa, Raf De Moor, Masaki Yoshida, Dee Lin, David bin-chia Wu, Samantha Craigie, Imtiaz A. Samjoo, Hiroshi Kitamura
Monday, May 18 – Poster Session 2
- EE166: Multi-Indication Budget Impact Analysis of Subcutaneous IgPro20 Pre-filled Syringes for the Treatment of PID, SID, and CIDP in Italy
Authors: Batyrkhan Kuatov, MSc, Alanna MacDonald, BSc, MSc, Stacey Priest, BSc, MSc, Diana Tran, BS, MSc, Laurence UNDREINER, MSc, MBA, Melike INKAYA TASKIN, BSc, MBA, Jonathan Galduf, MSc, PharmD, Sara Villa, MSc
- MSR80: Accelerating Evidence Generation: Leveraging LLMs for Full-Text Study Selection
Authors: Christopher Olsen, BHSc, Jayson Brian Habib, MPH, Elizabeth Salvo-Halloran, MSc, Sumeet Singh, BScPhm, MSc, Nicole Ferko, MSc.
- EE106: A Hospital‑Level Cost Calculator Comparing Rubidium Positron Emission Tomography (PET) and Flurpiridaz PET for Myocardial Perfusion Imaging: A Conceptual Framework
Authors: Kate Landry, MSc, Anna Zhou, MSc, Arturo Cabra, BS, MSc
- MSR93: Beyond the hype: Do Existing Validation Methods and Gold Standards prove the Value of Generative AI Applications for HEOR?
Authors: Tim Disher, BSc, RN, PhD, Nicole Ferko, MSc, Kevin Kallmes, JD, MA
Tuesday, May 19 – Poster Session 3
- SA26: Feasibility of Indirect Treatment Comparisons for OAV101 IT in Spinal Muscular Atrophy
Authors: Nicholas Riley, Almuth Marx, Orlando Dohring, IFTekhar KHAN, PhD, Rabiah Begum, BSc, MSc, PhD, Emmet Campbell, Sajjad Rafiq, MSc, PhD, Grace McCarthy, MSc, Christopher Drudge, PhD, Niki Srikanth, Roya Gavanji, Paul Spin, PhD, Pamela Vo, MS, PharmD - HTA40: The Role of Surrogacy Analysis in US and Canadian Health Technology Submissions: A Thematic and Temporal Review
Authors: Tracy Westley, MScPH, Di Wang, MSc, Yu-Chun Chien, MSc, Paul Spin, PhD - EE232: Cost-Effectiveness of Lenacapavir Versus Oral and Injectable PrEP Options for HIV Prevention in the United States
Authors: JEANPIERRE COAQUIRA CASTRO, MPH, David Cameron, MSc, Alice Hsiao, PharmD, Kirk Szafranski, MSc, James Class, PhD, Meghan Watson, MSc, Patrick Sullivan, DVM, PhD
Tuesday, May 19 – Poster Session 4
- SA46: Feasibility assessment of indirect treatment comparison between off-label rituximab and novel treatments in patients with warm autoimmune hemolytic anemia
Authors: Mahmoud Hashim, PhD, Alexa Sibiga, BSc, Teige Bourke, PhD, Sumeet Singh, MSc, Alexander M. Litvintchouk, PharmD, Ann Leon, PharmDMahmoud Hashim, PhD, Alexa Sibiga, BSc, Teige Bourke, PhD, Sumeet Singh, MSc, Alexander M. Litvintchouk, PharmD, Ann Leon, PharmD - CO154: Comparing 1.5% Ruxolitinib Cream and Other Therapies for Pediatric Patients with Atopic Dermatitis: A Systematic Literature Review and Network Meta-Analysis
Authors: Vimal H. Prajapati, MD, Kerri Purdy, MD, Alexander Luther, PhD, Becky Hooper, MSc, Nikita Sir, BHSc, Christopher Drudge, PhD, MPH, Heather Cameron, PhD, Grace K. Wong, PhD, Mehdi Larbi, MSc - EE416: The Economic Benefit of a Pre-filled Syringe as a Route of Administration: A Targeted Literature Review
Authors: Kunal Shastri, MSc, Celia Demont, PharmD, Nathashi Jayawardena, MSc, Liu Zhang, PhD, Lisa Kaindl, MSc, Kerise Clarke, MSc, Margaret H. Ainslie-Garcia, MSc
Wednesday, May 20 – Poster Session 5
- MSR204: Methodological Considerations of Network Meta-Analyses: Accounting for Differences in Maintenance Study Designs
Authors: Becky Hooper, MSc, Elizabeth Salvo-Halloran, MSc, Sarah Walsh, MSc, Maxwell Jones, MPH, Alicyia Walczyk Mooradally, PhD, Jason Steenkamp, BSc - EE434: Development of a cost utility model to assess the incremental cost effectiveness of continuous dual glucose ketone monitoring system versus continuous glucose monitoring system in people with diabetes
Authors: Johan Jendle, MD, PhD, Mark Moses, Kirk Szafranski, MSc, Donghyun Lee, PhD, Tiegh Taylor, PhD, Fleur Levrat Guillen, PharmD